Recent studies have revealed that the expression of Beclin-1 is decreased in various human cancer types, such as breast [10], cervical [11], esophageal [12], lung cancers [13,14], hepatocellular carcinoma [15], and cutaneous melanoma [16]. Here, BECN1 is linked to hepatocellular carcinoma.